Debt / revenue moved 1656 bp higher
Debt / revenue changed +1656 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
18.11%→34.68%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →NVDA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net debt changed across a sign change
Net debt changed +444.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
-$3.2B→$10.9B4 prior comparisons
Capital expenditure increased 41.3%
Capital expenditure changed +41.3% from the comparable as-filed period.
$1.9B→$2.7B3 prior comparisons
Receivables / revenue moved 604 bp higher
Receivables / revenue changed +604 basis points from the comparable as-filed period.
59.49%→65.54%2 prior comparisons
Working capital / assets moved 719 bp lower
Working capital / assets changed -719 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
55.39%→48.21%4 prior comparisons
Operating cash flow / net income decreased 30.6%
Operating cash flow / net income changed -30.6% from the comparable as-filed period.
0.58→0.42 prior comparisons
Capex / revenue moved 127 bp lower
Capex / revenue changed -127 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.05%→2.78%2 prior comparisons
Free-cash-flow margin moved 658 bp lower
Free-cash-flow margin changed -658 basis points from the comparable as-filed period.
28.82%→22.24%2 prior comparisons
Operating cash-flow margin moved 785 bp lower
Operating cash-flow margin changed -785 basis points from the comparable as-filed period.
32.87%→25.02%2 prior comparisons
Stock-based compensation increased 24.8%
Stock-based compensation changed +24.8% from the comparable as-filed period.
$1.6B→$2.0B2 prior comparisons
SBC / revenue moved 137 bp lower
SBC / revenue changed -137 basis points from the comparable as-filed period.
3.47%→2.11%2 prior comparisons
Selling, general & administrative increased 20.7%
Selling, general & administrative changed +20.7% from the comparable as-filed period.
$1.1B→$1.4B2 prior comparisons
R&D / revenue moved 185 bp lower
R&D / revenue changed -185 basis points from the comparable as-filed period.
9.18%→7.33%2 prior comparisons
Current ratio increased 8.9%
Current ratio changed +8.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
4.21→4.594 prior comparisons
Inventory / revenue moved 81 bp higher
Inventory / revenue changed +81 basis points from the comparable as-filed period.
32.01%→32.82%2 prior comparisons
Shares outstanding decreased 0.8%
Shares outstanding changed -0.8% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
24,300,000,000→24,100,000,0008 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.